Amygdalohippocampectomy: A Solution to Drug-Resistant Seizures
By: Andrew Yee Amygdalohippocampectomy:Amygdalohippocampectomy is a surgical procedure used to treat all drug-resistant epilepsy(DRE) that originates in the hippocampus and/or the temporal lobe. The main form of epilepsythat amygdalohippocampectomy targets is mesial temporal lobe epilepsy (MTLE). Mesialtemporal lobe epilepsy typically results from pathologies in the hippocampus, mainlyhippocampal sclerosis (Estekhareh et al., 2022). Since the seizures […]